This document provides notes on mortality and disease burden estimates for WHO member states in 2002. It summarizes the data sources and methods used to estimate total deaths, cause-specific deaths, and disability-adjusted life years (DALYs) for each member state. Member state estimates are categorized into four levels of evidence based on the types of data available. Color coding is used to denote the levels of evidence for total deaths, cause-specific deaths, and DALYs in subsequent tables for quick reference.

1. World Health Organization
Organisation Mondiale de la Santé
Department of NOTES FOR TABLES
Measurement and Health Information
December 2004
(a) The figures in these table are generally consistent with the Annex Tables published in the World Health Report 2004. Further updates have been carried out for malaria and
HIV/AIDS. Initial WHO estimates and technical explanations were sent to Member States for comment in 2003. Comments or data provided in response were discussed with them
and incorporated where possible. The estimates reported here should, however, still be interpreted as the best estimates of WHO rather than the official viewpoint of Member States.
Methods and data sources are summarized in the Statistical Annex Explanatory Notes of the World Health Report 2004 and in more detail in Discussion Paper 54
(www.who.int/evidence/bod)
(b) Global Burden of Disease (GBD) cause categories are defined in Discussion Paper 54, Annex Table 3. Underlying causes of death as defined by the International Classification of
Diseases (ICD) classification rules (www.who.int/classifications/icd)
(c) The data sources and methods used for the estimation of total deaths (all causes) for each Member State are summarized into four levels of evidence. Further details of data sources
and methods for each Member State are given in Discussion Paper 54 (www.who.int/evidence/bod).
Level 1a Complete death registration data available for years 2001 and/or 2002.
Level 1b Complete death registration data available for an earlier time period. All cause mortality projected to 2002.
Level 2a Death registration data available for years 2001 and/or 2002. Completeness for latest year estimated using standard demographic methods for child deaths under age 5
and for deaths at ages 5 and over. Estimated completeness used to adjust death registration data.
Level 2b Death registration data available for available for an earlier time period. Completeness for latest year estimated using standard demographic methods for child deaths
under age 5 and for deaths at ages 5 and over. Estimated completeness used to adjust death registration data and then all cause mortality was projected to 2002.
Level 3a Country information for years 2001 and/or 2002 available on levels of child mortality (between ages 0 and 5) and adult mortality (between ages 15 and 60). WHO
modified logit life table system used with global standard to estimate all cause mortality.
Level 3b Country information available for an earlier time period on levels of child mortality (between ages 0 and 5) and adult mortality (between ages 15 and 60). Child and
adult mortality levels were projected to 2002 and the WHO modified logit life table system used with global standard to estimate all cause mortality.
Level 4a Country information for years 2001 and/or 2002 available on level of child mortality (between ages 0 and 5) only. Levels of adult mortality excluding HIV/AIDS and war
deaths predicted from child mortality. HIV/AIDS and war deaths added separately and WHO modified logit life table system used with global standard to estimate all cause
mortality.
Level 4b Country information prior to 2001 available on level of child mortality (between ages 0 and 5) only. Levels of adult mortality excluding HIV/AIDS and war deaths
predicted from projected 2002 HIV/AIDS-free child mortality. HIV/AIDS and war deaths added separately and WHO modified logit life table system used with global standard to
estimate all cause mortality.

2. (d) The data sources and methods used for the estimation of deaths by cause for each Member State are summarized into four levels of evidence. Additional information for estimating
country-level deaths due to certain specific causes were obtained from studies, WHO technical Programmes and UNAids for the following conditions: AIDS, tuberculosis, measles,
pertussis, poliomyelitis, tetanus, acute lower respiratory infections, Chagas, maternal conditions, perinatal conditions, cancers, drug use disorders, rhumathoid arthritis and war.
Further details of data sources and methods for each Member State are given in Discussion Paper 54 (www.who.int/evidence/bod).
Level 1a Complete death registration data with cause of death coded using ICD-9 or ICD-10 available for years 2001 and/or 2002. Less than 10% of deaths coded to ICD codes
for “symptoms, signs, and ill-defined conditions”, injuries where the intent is not determined; cardiovascular "garbage" codes, and cancer deaths coded to categories for
secondary or unspecified sites.
Level 1b Complete death registration data available . Complete death registration data with cause of death coded using ICD-9 or ICD-10 available for for an earlier time period.
Less than 10% of deaths coded to ICD codes for “symptoms, signs, and ill-defined conditions”, injuries where the intent is not determined; and cardiovascular and cancer
"garbage" codes.
Level 2a Death registration data available for years 2001 and/or 2002. Adjustments to cause of death distribution required for incomplete registration and/or for use of non-ICD-9
or ICD-10 coding and/or for the more than 10% of deaths coded to ill-defined conditions, and cardiovascular, cancer and injury "garbage" codes.
Level 2b Death registration data available for latest year earlier than 2001. Adjustments to cause of death distribution required for incomplete registration and/or for use of non-
ICD-9 or ICD-10 coding and/or for the more than 10% of deaths coded to ill-defined conditions, and cardiovascula, cancer and injury "garbage" codes.
Level 3 Country information on causes of death available based on verbal autopsy methods.
Level 4. Country information on causes of death not available for most causes. Cause of death modelling used to estimate broad distribution of causes of death for Groups I, II
and III by age and sex for the country level of all cause mortality and per capita income. Cause of death patterns within the three major cause groups based on death registration
data from other countries in the region. Further country-level information and data on specific causes listed above was also used.
(e) UN estimates of de-facto population (2002 Revision). Estimated death rates by age, sex for underlying causes of death as defined by the ICD classification rules, are applied to the
UN estimates of de-facto resident population for 2002 to give numbers of expected deaths by cause for each Member State.
(f) Estimated 95% uncertainty ranges for the expected number of total deaths for 2002. Uncertainty in population estimates is not included and the uncertainty ranges relate to underlying
death rates estimated in the life table for each Member State not to the realized numbers of deaths actually occurring in 2002. Methods for estimating life table uncertainty are
summarized in the Statistical Annex Explanatory Notes of the World Health Report 2004 and in more detail in Discussion Paper 10 (www.who.int/evidence). In countries with a
substantial HIV epidemic or a war, estimates of the level and uncertainty range of the magnitude of the HIV epidemic or of war deaths were incorporated into the life table uncertainty
analysis.
(g) Does not include liver cancer and cirrhosis deaths or DALYs resulting from chronic hepatitis virus infection.
(h) This cause category includes 'Causes arising in the perinatal period' as defined in the International Classification of Diseases, principally low birthweight, prematurity, birth asphyxia
and birth trauma, and does not include all causes occurring in the perinatal period.
(i) Standard DALYs with age-weighting and time discounting as reported in World Health Report 2004 (see second box below).
(j) The data sources and methods used for the estimation of the YLL (premature mortality) component of DALYs are summarized as described in notes (c) and (d). YLD estimates by
cause for Member States are based on the GBD analyses of incidence, prevalence, duration and severity of conditions for the relevant epidemiological subregion, together with
country-level and subregional mortality differentials, and other national and subnational level information available to WHO. Two levels of evidence are distinguished as listed below.
Further details of data sources and methods for each Member State are given in Discussion Paper 54 (www.who.int/evidence/bod).
Level 3 Country data on causes of death (Levels 1 to 3) used to adjust regional YLD distributions for causes with significant case fatality. Partial country-specific information on
incidence or prevalence of non-fatal causes available.

3. Level 4. Level 4 information on causes of death and regional estimates of YLD used for most causes. Partial country-specific information on incidence or prevalence of some
non-fatal causes available.
(j) Cause-specific death rates were age-standardized to the WHO global standard population (see Discussion Paper 31, www.who.int/evidence). Age-standardized death rates are
calculated by applying age-specific death rates for the Member State to a global standard population. Comparison of cause-specific mortality risks across countries is facilitated by the
use of age-standardized death rates to adjust for differences in population age distributions.
MORTALITY AND BURDEN OF DISEASE ESTIMATES FOR WHO MEMBER STATES IN 2002
This workbook contains WHO estimates of mortality and burden of disease for WHO Member States for the year 2002. These estimates are based on version 3 of the Global Burden
of Disease (GBD) study (1) as published in the World Health Report 2004 (2), with some additional adjustments for later revisions in HIV/AIDS mortality and burden (3) and draft
revisions for malaria, schistosomiasis and intestinal helminth infections. Mortality estimates are based on analysis of latest available national information on levels of mortality and
cause distributions as at late 2003. YLD estimates are based on the GBD analyses of incidence, prevalence, duration and severity of conditions for the relevant epidemiological
subregion, together with national and subnational level information available to WHO (1). The GBD uses the latest population estimates for WHO Member States prepared by the UN
Population Division (4).
These summary tables represent the best estimates of WHO, based on the evidence available to it in mid-2004, rather than the official estimates of Member States. They have been
computed using standard categories and methods to ensure cross-national comparability and may not be the same as official national estimateis produced using alternate, potentially
equally rigorous methods. Data and methods used for estimating mortality and burden of disease for WHO Member states, and for quantifying uncertainty, are also summarized in a
Working Paper (5).
The work leading to these prior estimates of national burden of disease was undertaken by the WHO Evidence and Information for Policy cluster in collaboration with WHO technical
programmes and with scientists worldwide. Documentation and GBD 2000 summary tables are available on the WHO website (http://www.who.int/evidence/bod), together with
software tools and a National Burden of Disease Manual providing guidelines for conducting an NBD study (6).
References
1. Mathers CD, Bernard C, Iburg K, Inoue M, Ma Fat D, Shibuya K, Stein C, Tomijima, N (2003). The Global Burden of Disease in 2002: data sources, methods and results. Geneva,
World Health Organization (GPE Discussion Paper No. 54). Available at http://www.who.int/evidence
2. World Health Organization. World Health Report 2004: changing history. Available at http://www.who.int/whr
3. UNAIDS. 2004 report on the global AIDS epidemic. 4th global report. Geneva: UNAIDS, 2004. Available at http://www.unaids.org
4. United Nations Population Division. World Population Prospects - the 2002 revision. New York: United Nations, 2003.
5. Mathers CD (2005). Uncertainty and data availability for the global burden of disease estimates 2000-2002. Evidence and Information for Policy Working Paper. Geneva, World
Health Organization. Available at http://www.who.int/evidence/bod
6. Mathers CD, Vos T, Lopez AD, Ezzati M. National Burden of Disease Studies: A Practical Guide. Edition 1.1. 2001. Geneva, World Health Organization, Global Program on
Evidence for Health Policy. Available at http://www.who.int/evidence/nbd
DISABILITY ADJUSTED LIFE YEARS
The Disability Adjusted Life Year or DALY is a health gap measure that extends the concept of potential years of life lost due to premature death (PYLL) to include equivalent years of
‘healthy’ life lost by virtue of being in states of poor health or disability (1). The DALY combines in one measure the time lived with disability and the time lost due to premature
mortality. One DALY can be thought of as one lost year of ‘healthy’ life and the burden of disease as a measurement of the gap between current health status and an ideal situation
where everyone lives into old age free of disease and disability.

4. DALYs for a disease or health condition are calculated as the sum of the years of life lost due to premature mortality (YLL) in the population and the years lost due to disability (YLD)
for incident cases of the health condition:
The years of life lost (YLL) basically correspond to the number of deaths multiplied by the standard life expectancy at the age at which death occurs. The basic formula for YLL
(without yet including other social preferences discussed below), is the following for a given cause, age and sex:
YLL = N x L
where:
N = number of deaths
L = standard life expectancy at age of death in years
Because YLL measure the incident stream of lost years of life due to deaths, an incidence perspective is also taken for the calculation of YLD. To estimate YLD for a particular cause
in a particular time period, the number of incident cases in that period is multiplied by the average duration of the disease and a weight factor that reflects the severity of the disease
on a scale from 0 (perfect health) to 1 (dead). The basic formula for YLD is the following (again, without applying social preferences):
YLD = I x DW x L
where:
I = number of incident cases
DW = disability weight
L = average duration of the case until remission or death (years)
Egalitarian principles were explicitly built into the DALY, and the Global Burden of Disease Study used the same values for all regions of the world (2) . It used the same life
expectancy ‘ideal’ standard for all population subgroups and it excluded all non-health characteristics (such as race, socioeconomic status or occupation) apart from age and sex from
consideration in calculating lost years of healthy life. Most importantly, it used the same ‘disability weight’ for everyone living a year in a specified health state. Additionally, 3% time
discounting and non-uniform age weights which give less weight to years lived at young and older ages were used in calculating DALYs for the original Global Burden of Disease
study. These value choices have continued to be used for the Global Burden of Disease 2000 study results reported in recent World Health Reports and in these tables.
With non-uniform age weights and 3% discounting, a death in infancy corresponds to 33 DALYs, and deaths at ages 5 to 20 to around 36 DALYs. Thus a disease burden of 3,300
DALYs in a population would be the equivalent of 100 infant deaths or to approximately 5,500 persons aged 50 years living one year with blindness (disability weight 0.6).
References
1. Murray CJL, Salomon JA, Mathers CD, Lopez AD (eds.) (2002). Summary measures of population health: concepts, ethics, measurement and applications. WHO, Geneva.
Available at http://www.who.int/pub/smph/en/index.html
2. Murray CJL, Lopez AD (1996). The Global Burden of Disease. Cambridge: Harvard University Press.

5. World Health Organization
Organisation Mondiale de la Santé
Department of COLOUR CODES FOR LEVELS OF EVIDENCE
Measurement and Health Information
December 2004
Columns containing estimates of deaths or DALYs for WHO Member States in 2002 are colour-coded in the following sheets to summarize the levels of evidence and uncertainty. Four levels
of evidence for all cause mortality, cause-specific mortality, and DALYs are defined in the Notes sheet. Three colour codes are used to denote the following levels:
Total Causes of
mortality death YLD
Level 1 Level 1 Level 3 Death registration data, complete or incomplete, containing useable information on causes of death is available for the country, and
or Level 2 or Level 2 used to adjust regional YLD distributions for causes with significant case fatality. Partial country-specific information on incidence or
prevalence of non-fatal causes available.
Total mortality or causes of death Other forms of information on child and adult mortality or causes of death (eg. verbal autopsy) available. Country-specific information on
have level 3 evidence, neither is mortality for specific causes available.Partial country-specific information on incidence or prevalence of non-fatal causes available.
level 4.
Level 4 OR Level 4 Level 4 Country information on level of adult mortality not available and it was predicted from child mortality level OR cause of death information
for most causes not available, and cause pattern predicted using cause-of-death models. Partial country-specific information on
incidence or prevalence of non-fatal causes available.
Note that levels of evidence will vary for specific causes within a country, and the above colour coded scheme does not attempt to provide that level of detail for most causes. For
tuberculosis, HIV/AIDS, CHagas disease and maternal mortality, specific colour codes have been used to provide an indication of when country-level data were used for those causes, for
countries where the general level of evidence is level 4 (pink).
Estimated 95% uncertainty ranges for the expected number of total deaths for 2002 are given for each country in the 'Deaths 2002' sheet and provide some indication of the level of
uncertainty for estimates in that country. Cause-specific estimates will generally have even greater relative uncertainty ranges, as will DALY estimates, with the possible exception of some
causes such as HIV/AIDS where separate country-specific analyses have been used. For more details on data source, methods and uncertainty refer to the GBD working papers
referenced below.
References
1. Mathers CD, Bernard C, Iburg K, Inoue M, Ma Fat D, Shibuya K, Stein C, Tomijima, N (2003). The Global Burden of Disease in 2002: data sources, methods and results. Geneva, World
Health Organization (GPE Discussion Paper No. 54). Available at http://www.who.int/evidence
2. Mathers CD (2005). Uncertainty and data availability for the global burden of disease estimates 2000-2002. Evidence and Information for Policy Working Paper. Geneva, World Health
Organization. Available at http://www.who.int/evidence/bod

6. GBD Antigua and
code GBD cause (b) Afghanistan Albania Algeria Andorra Angola Barbuda Argentina Armenia Australia
Data sources - level of evidence
All cause mortality (c) Level 4b Level 2b Level 3b Level 3b Level 4b Level 3b Level 1a Level 2a Level 1a
Cause-specific mortality (d) Level 4 Level 2b Level 4 Level 4 Level 4 Level 2b Level 2a Level 2a Level 2b
Population ('000) (e) 22,930 3,141 31,266 69 13,184 73 37,981 3,072 19,544
W000 All Causes 484.5 22.1 173.3 0.6 306.6 0.6 281.4 26.1 126.6
Lower uncertainty bound (f) 347.6 19.3 158.0 0.5 255.3 0.5 276.6 23.6 124.1
Upper uncertainty bound (f) 695.8 28.0 188.4 0.6 434.8 0.6 286.6 33.8 128.8
W001 I. Communicable, maternal, perinatal and 317.2 1.8 56.9 0.0 230.3 0.1 36.2 1.3 5.5
W002 nutritional conditions
A. Infectious and parasitic diseases 169.3 0.2 30.2 0.0 143.0 0.0 15.6 0.5 1.8
W003 1. Tuberculosis 21.1 0.0 0.6 0.0 4.8 - 0.8 0.2 0.1
W004 2. STDs excluding HIV 0.3 0.0 2.1 0.0 2.3 0.0 0.0 0.0 0.0
W005 a. Syphilis 0.1 0.0 2.0 0.0 2.3 0.0 0.0 0.0 0.0
W006 b. Chlamydia 0.1 - 0.0 - 0.0 - - - -
W007 c. Gonorrhoea 0.0 - 0.0 - 0.0 - - 0.0 -
W009 3. HIV/AIDS 0.0 0.0 0.3 0.0 21.1 0.0 1.8 0.2 0.1
W010 4. Diarrhoeal diseases 41.2 0.0 8.1 0.0 48.8 0.0 0.4 0.1 0.0
W011 5. Childhood-cluster diseases 15.5 0.0 4.1 0.0 12.4 0.0 0.0 0.0 0.0
W012 a. Pertussis 6.6 - 0.6 - 4.2 - 0.0 0.0 0.0
W013 b. Poliomyelitis 0.0 - - 0.0 - - - - 0.0
W014 c. Diphtheria 0.0 - 0.0 - 0.1 - - 0.0 -
W015 d. Measles 2.2 - 3.4 - 6.2 - - 0.0 -
W016 e. Tetanus 6.7 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0
W017 6. Meningitis 8.3 0.0 0.2 0.0 0.6 0.0 0.4 0.0 0.1
W018 7. Hepatitis B (g) 1.0 0.0 0.5 0.0 0.8 0.0 0.1 0.0 0.0
W019 Hepatitis C (g) 0.5 0.0 0.2 0.0 0.4 0.0 0.1 0.0 0.0
W020 8. Malaria 0.9 - 0.0 0.0 17.9 - - 0.0 0.0
W021 9. Tropical-cluster diseases 0.4 0.0 1.0 0.0 3.1 - 0.7 - -
W022 a. Trypanosomiasis 0.0 - 0.7 - 1.3 - - - -
W023 b. Chagas disease - - - - - - 0.7 - -
W024 c. Schistosomiasis 0.0 - 0.1 - 1.5 - - - -
W025 d. Leishmaniasis 0.4 0.0 0.2 0.0 0.2 - 0.0 - -
W026 e. lymphatic filariasis 0.0 - - - - - - - -
W027 f. Onchocerciasis - - - - - - - - -
W028 10. Leprosy 0.0 - 0.1 0.0 0.0 - 0.0 - -
W029 11. Dengue 0.0 - 0.0 - 0.0 - - - 0.0
W030 12. Japanese encephalitis - - - - - - - - -
W031 13. Trachoma - - - - - - - - -
W032 14. Intestinal nematode infections 0.0 0.0 0.1 - 0.1 - 0.0 - 0.0
W033 a. Ascariasis 0.0 - 0.0 - 0.0 - - - -
W034 b. Trichuriasis - - 0.0 - 0.0 - - - -
W035 c. Hookworm disease 0.0 - 0.1 - 0.0 - - - -
W038 B. Respiratory infections 56.7 1.0 14.1 0.0 47.8 0.0 12.6 0.3 2.8
W039 1. Lower respiratory infections 55.9 1.0 13.8 0.0 47.0 0.0 12.6 0.3 2.8
W040 2. Upper respiratory infections 0.8 0.0 0.3 0.0 0.8 - 0.0 0.0 0.0
W041 3. Otitis media 0.0 - 0.0 0.0 0.1 - - 0.0 0.0
W042 C. Maternal conditions 18.8 0.0 1.0 0.0 11.3 0.0 0.3 0.0 0.0
W049 D. Perinatal conditions (h) 62.0 0.5 10.6 0.0 19.0 0.0 5.9 0.5 0.7
W050 1. Low birth weight 34.2 0.1 4.6 0.0 8.2 0.0 1.6 0.2 0.0
W051 2. Birth asphyxia and birth trauma 17.2 0.2 4.4 0.0 7.8 0.0 2.7 0.1 0.2
W053 E. Nutritional deficiencies 10.4 0.1 1.0 0.0 9.1 0.0 1.9 0.0 0.2
W054 1. Protein-energy malnutrition 7.3 0.0 0.5 0.0 8.2 0.0 1.4 0.0 0.1
W055 2. Iodine deficiency 0.2 - 0.0 - 0.0 - - - -
W056 3. Vitamin A deficiency 0.0 0.0 0.2 - 0.6 - - - -
W057 4. Iron-deficiency anaemia 1.3 0.0 0.3 0.0 0.3 0.0 0.4 0.0 0.1
W059 II. Noncommunicable diseases 140.6 18.3 93.9 0.5 51.1 0.5 225.1 23.6 113.1
W060 A. Malignant neoplasms 18.9 3.9 16.9 0.2 9.2 0.1 59.9 4.7 36.5
W061 1. Mouth and oropharynx cancers 2.3 0.1 0.8 0.0 1.0 0.0 1.0 0.1 0.7
W062 2. Oesophagus cancer 2.3 0.1 0.2 0.0 0.5 0.0 2.5 0.1 1.1
W063 3. Stomach cancer 1.2 0.6 1.4 0.0 1.4 0.0 3.4 0.5 1.3
W064 4. Colon and rectum cancers 1.0 0.1 1.3 0.0 0.3 0.0 7.4 0.4 5.3
W065 5. Liver cancer 0.6 0.6 0.2 0.0 0.5 - 1.9 0.3 0.8
W066 6. Pancreas cancer 0.2 0.1 0.4 0.0 0.1 0.0 3.6 0.2 1.8
W067 7. Trachea, bronchus, lung cancers 1.3 0.9 2.3 0.0 0.4 0.0 8.8 1.0 7.0
W068 8. Melanoma and other skin cancers 0.1 0.1 0.1 0.0 0.3 - 0.9 0.1 1.5
W069 9. Breast cancer 2.0 0.2 1.7 0.0 0.9 0.0 6.0 0.5 2.7
W070 10. Cervix uteri cancer 0.3 0.0 1.0 0.0 0.9 0.0 1.1 0.1 0.3
W071 11. Corpus uteri cancer 0.1 0.1 0.1 0.0 0.1 0.0 1.9 0.1 0.3
W072 12. Ovary cancer 0.4 0.0 0.4 0.0 0.2 0.0 1.2 0.1 0.8
W073 13. Prostate cancer 0.3 0.2 0.7 0.0 0.6 0.0 4.4 0.1 3.0
W074 14. Bladder cancer 0.7 - 1.4 0.0 0.3 0.0 1.5 0.1 0.9
W075 15. Lymphomas, multiple myeloma 1.9 0.1 1.3 0.0 0.6 0.0 2.6 0.1 2.7
W076 16. Leukaemia 1.3 0.2 0.4 0.0 0.2 0.0 2.2 0.2 1.5
W078 B. Other neoplasms 2.1 0.3 0.3 0.0 0.2 0.0 2.4 0.0 0.8
W079 C. Diabetes mellitus 2.7 0.2 3.0 0.0 1.6 0.0 9.6 1.6 3.2
W080 D. Endocrine disorders 3.3 0.1 0.8 0.0 0.7 0.0 2.8 0.1 1.4
W081 E. Neuropsychiatric conditions 8.8 0.6 2.7 0.0 2.4 0.0 5.7 0.3 7.4
W082 1. Unipolar depressive disorders 0.0 0.0 - 0.0 - - 0.0 0.0 0.1
W083 2. Bipolar disorder - - - 0.0 - - - 0.0 0.0
W084 3. Schizophrenia 0.0 0.0 - 0.0 - - 0.0 0.0 0.0
W085 4. Epilepsy 0.8 0.1 1.1 0.0 1.1 0.0 0.3 0.1 0.3
W086 5. Alcohol use disorders 0.1 0.0 0.2 0.0 0.2 0.0 0.7 0.0 0.3
W087 6. Alzheimer and other dementias* 0.1 0.0 0.3 0.0 0.1 0.0 2.2 0.1 4.0
W088 7. Parkinson disease 0.0 0.0 0.3 0.0 0.1 - 0.6 0.0 0.9
W089 8. Multiple sclerosis 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1
W090 9. Drug use disorders 5.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.5
W091 10. Post-traumatic stress disorder - 0.0 - - - - - 0.0 -
W092 11. Obsessive-compulsive disorder - - - - - - - - -
W093 12. Panic disorder - - - - - - - - -
W094 13. Insomnia (primary) - - - - - - - - -
W095 14. Migraine - - - - - - - - -
W098 F. Sense organ diseases 0.1 0.0 - 0.0 - - - - 0.0
W099 1. Glaucoma - - - 0.0 - - - - -
W100 2. Cataracts - - - - - - - - -
W101 3. Vision disorders, age-related - - - - - - - - -
W102 4. Hearing loss, adult onset - - - - - - - - -
W104 G. Cardiovascular diseases 67.6 11.5 46.9 0.2 22.0 0.2 93.3 14.2 47.2
W105 1. Rheumatic heart disease 1.9 0.0 0.8 0.0 0.6 - 0.2 0.2 0.2
W106 2. Hypertensive heart disease 7.5 0.4 2.5 0.0 1.2 0.0 4.5 0.5 1.1
W107 3. Ischaemic heart disease 33.2 4.0 14.9 0.1 7.1 0.1 34.3 8.5 25.5
W108 4. Cerebrovascular disease 11.5 4.2 16.2 0.1 7.6 0.1 22.7 4.2 11.7
05/18/2010 + ^

7. W109 5. Inflammatory heart diseases 2.3 0.1 1.6 0.0 1.1 0.0 3.1 0.6 1.0
W111 H. Respiratory diseases 8.6 0.7 10.9 0.0 6.1 0.0 27.7 1.1 7.7
W112 1. Chronic obstructive pulmonary disease 3.3 0.3 5.0 0.0 2.3 0.0 5.1 0.8 5.2
W113 2. Asthma 2.3 0.3 0.6 0.0 0.3 0.0 0.8 0.1 0.4
W115 I. Digestive diseases 12.4 0.5 6.0 0.0 4.0 0.0 11.9 1.0 4.2
W116 1. Peptic ulcer disease 0.4 0.0 0.6 0.0 0.4 0.0 0.4 0.2 0.5
W117 2. Cirrhosis of the liver 5.5 - 2.1 0.0 1.4 0.0 2.6 0.5 0.9
W118 3. Appendicitis 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0
W120 J. Genitourinary diseases 7.0 0.4 3.6 0.0 2.7 0.0 7.5 0.4 2.8
W121 1. Nephritis and nephrosis 6.3 0.4 3.3 0.0 2.5 0.0 6.4 0.2 2.1
W122 2. Benign prostatic hypertrophy 0.1 0.0 0.1 0.0 0.0 - 0.0 0.1 0.0
W124 K. Skin diseases 0.2 0.0 2.0 0.0 0.0 0.0 0.6 0.0 0.3
W125 L. Musculoskeletal diseases 0.2 0.0 0.1 0.0 0.3 0.0 0.6 0.1 0.9
W126 1. Rheumatoid arthritis 0.0 0.0 0.0 0.0 0.0 - 0.1 0.0 0.2
W127 2. Osteoarthritis 0.0 0.0 - 0.0 - - 0.0 0.0 0.1
W131 M. Congenital anomalies 8.6 0.1 0.7 0.0 1.8 0.0 3.1 0.2 0.6
W143 N. Oral conditions 0.0 0.0 - 0.0 - - - - 0.0
W144 1. Dental caries - - - - - - - - -
W145 2. Periodontal disease - - - - - - - - -
W146 3. Edentulism - - - - - - - - -
W148 III.Injuries 26.8 2.0 22.5 0.0 25.2 0.0 20.1 1.2 8.0
W149 A. Unintentional injuries 18.2 1.7 12.9 0.0 17.2 0.0 12.8 1.0 5.5
W150 1. Road traffic accidents 8.4 0.1 5.4 0.0 7.6 0.0 4.4 0.3 1.7
W151 2. Poisonings 1.0 0.0 1.0 0.0 1.2 0.0 0.2 0.1 0.8
W152 3. Falls 1.3 0.0 0.8 0.0 0.7 - 0.4 0.0 0.6
W153 4. Fires 1.2 0.0 1.2 0.0 1.5 0.0 0.5 0.0 0.1
W154 5. Drownings 2.4 0.0 1.2 0.0 2.4 0.0 1.0 0.1 0.2
W155 6. Other unintentional injuries 3.9 1.5 3.4 0.0 3.8 0.0 6.4 0.4 2.0
W156 B. Intentional injuries 8.6 0.3 9.7 0.0 7.9 0.0 7.3 0.2 2.5
W157 1. Self-inflicted injuries 1.5 0.1 0.9 0.0 1.1 0.0 3.9 0.1 2.2
W158 2. Violence 0.9 0.2 3.7 0.0 5.2 0.0 3.3 0.1 0.3
W159 3. War 5.9 0.0 5.0 - 1.7 - - 0.0 -
Refer to Notes sheet for notes on this table.
05/18/2010 + ^

8. All cause mortality (c) Level 4b Level 2b Level 3b Level 3b Level 4b Level 3b Level 1a Level 2a Level 1a
Cause-specific mortality (d) Level 4 Level 2b Level 4 Level 4 Level 4 Level 2b Level 2a Level 2a Level 2b
Incidence, prevalence, severity, duration (j) Level 4 Level 3 Level 4 Level 4 Level 4 Level 3 Level 3 Level 3 Level 3
Population ('000) (e) 22,930 3,141 31,266 69 13,184 73 37,981 3,072 19,544
W000 All Causes 17,011 503 5,500 9 10,757 13 6,293 516 2,154
W001 I. Communicable, maternal, perinatal and 11,708 70 2,064 0 8,174 2 784 64 110
W002 nutritional conditions
A. Infectious and parasitic diseases 5,814 10 1,049 0 4,888 1 342 21 35
W003 1. Tuberculosis 523 1 20 0 133 0 18 5 1
W004 2. STDs excluding HIV 52 2 135 0 99 0 37 3 4
W005 a. Syphilis 3 0 44 0 61 0 4 0 0
W006 b. Chlamydia 22 1 39 0 15 0 19 2 3
W007 c. Gonorrhoea 26 1 51 0 22 0 14 1 1
W009 3. HIV/AIDS 0 0 9 0 641 0 64 5 4
W010 4. Diarrhoeal diseases 1,343 1 295 0 1,608 0 49 4 5
W011 5. Childhood-cluster diseases 585 1 155 0 473 0 12 1 5
W012 a. Pertussis 282 1 32 0 191 0 11 0 5
W013 b. Poliomyelitis 1 - 1 0 0 0 0 0 0
W014 c. Diphtheria 0 - 0 - 2 0 0 0 -
W015 d. Measles 80 0 121 - 216 0 0 0 -
W016 e. Tetanus 223 0 1 0 64 0 0 0 0
W017 6. Meningitis 459 1 5 0 29 0 14 1 3
W018 7. Hepatitis B (g) 26 0 8 0 24 0 1 0 0
W019 Hepatitis C (g) 13 0 3 0 11 0 1 0 0
W020 8. Malaria 64 - 0 0 681 - 0 1 0
W021 9. Tropical-cluster diseases 17 0 106 0 146 0 37 0 -
W022 a. Trypanosomiasis 0 - 24 - 41 - - - -
W023 b. Chagas disease - - - - - 0 35 - -
W024 c. Schistosomiasis 0 - 66 - 48 0 - - -
W025 d. Leishmaniasis 17 0 16 0 11 0 2 0 -
W026 e. lymphatic filariasis 0 - - - 45 - - - -
W027 f. Onchocerciasis - - - - 2 - - - -
W028 10. Leprosy 1 0 1 0 1 0 1 - 0
W029 11. Dengue 0 - 0 - 0 - - - 0
W030 12. Japanese encephalitis 1 - - - - - - - -
W031 13. Trachoma 5 - - - 4 - - - 0
W032 14. Intestinal nematode infections 13 0 76 - 40 0 6 0 0
W033 a. Ascariasis 6 - 58 - 32 0 1 0 -
W034 b. Trichuriasis 5 - 6 - 3 0 3 - -
W035 c. Hookworm disease 2 - 12 - 5 0 1 0 -
W038 B. Respiratory infections 2,067 20 315 0 1,634 0 96 8 13
W039 1. Lower respiratory infections 2,031 19 303 0 1,599 0 87 7 10
W040 2. Upper respiratory infections 28 0 4 0 28 0 2 0 1
W041 3. Otitis media 8 0 8 0 7 0 8 1 2
W042 C. Maternal conditions 942 5 145 0 499 0 53 4 9
W049 D. Perinatal conditions (h) 2,383 22 408 0 735 1 247 20 40
W050 1. Low birth weight 1,275 5 163 0 294 0 59 8 9
W051 2. Birth asphyxia and birth trauma 736 7 186 0 335 0 130 9 13
W053 E. Nutritional deficiencies 502 14 147 0 418 0 46 10 14
W054 1. Protein-energy malnutrition 338 2 50 0 345 0 28 1 0
W055 2. Iodine deficiency 13 9 12 - 8 - 1 0 -
W056 3. Vitamin A deficiency 1 0 3 - 22 - - 0 -
W057 4. Iron-deficiency anaemia 94 2 82 0 43 0 16 9 13
W059 II. Noncommunicable diseases 4,103 345 2,522 7 1,495 10 4,774 410 1,834
W060 A. Malignant neoplasms 353 45 174 1 117 1 565 57 306
W061 1. Mouth and oropharynx cancers 39 1 10 0 9 0 11 1 7
W062 2. Oesophagus cancer 35 0 2 0 5 0 19 0 8
W063 3. Stomach cancer 21 6 13 0 16 0 29 5 9
W064 4. Colon and rectum cancers 19 2 13 0 4 0 56 4 46
W065 5. Liver cancer 10 5 1 0 7 - 15 3 6
W066 6. Pancreas cancer 3 1 4 0 2 0 28 2 12
W067 7. Trachea, bronchus, lung cancers 17 9 20 0 5 0 81 10 52
W068 8. Melanoma and other skin cancers 2 1 1 0 3 0 8 1 13
W069 9. Breast cancer 38 4 22 0 10 0 63 7 34
W070 10. Cervix uteri cancer 5 1 13 0 11 0 19 2 4
W071 11. Corpus uteri cancer 2 2 1 0 1 0 30 3 4
W072 12. Ovary cancer 9 0 4 0 3 0 13 2 8
W073 13. Prostate cancer 2 2 4 0 3 0 23 1 18
W074 14. Bladder cancer 7 - 9 0 3 0 11 1 6
W075 15. Lymphomas, multiple myeloma 48 1 18 0 12 0 28 3 21
W076 16. Leukaemia 40 3 7 0 3 0 30 3 13
W078 B. Other neoplasms 41 4 4 0 5 0 25 0 4
W079 C. Diabetes mellitus 49 5 49 0 21 0 146 19 46
W080 D. Endocrine disorders 76 5 30 0 38 1 80 6 44
W081 E. Neuropsychiatric conditions 851 99 737 2 353 3 1,731 91 599
W082 1. Unipolar depressive disorders 288 37 227 1 81 1 457 38 187
W083 2. Bipolar disorder 52 7 88 0 32 0 82 7 32
W084 3. Schizophrenia 61 8 87 0 31 0 98 9 32
W085 4. Epilepsy 42 5 46 0 39 0 55 3 11
W086 5. Alcohol use disorders 3 5 6 0 16 1 462 3 72
W087 6. Alzheimer and other dementias* 12 4 18 0 7 0 90 6 81
W088 7. Parkinson disease 9 2 4 0 1 0 6 1 16
W089 8. Multiple sclerosis 5 1 6 0 2 0 9 1 5
W090 9. Drug use disorders 142 3 24 0 8 0 94 1 47
W091 10. Post-traumatic stress disorder 12 2 17 0 6 0 17 2 11
W092 11. Obsessive-compulsive disorder 14 4 41 0 16 0 45 4 8
W093 12. Panic disorder 26 3 39 0 14 0 40 3 17
W094 13. Insomnia (primary) 14 2 17 0 6 0 28 1 16
W095 14. Migraine 34 4 19 0 8 0 57 3 22
W098 F. Sense organ diseases 223 18 524 0 169 1 395 32 79
W099 1. Glaucoma 2 1 55 0 18 0 24 2 1
W100 2. Cataracts 106 2 302 0 98 0 127 3 1
W101 3. Vision disorders, age-related 17 6 53 0 17 0 123 12 12
W102 4. Hearing loss, adult onset 98 9 114 0 36 0 121 16 64
W104 G. Cardiovascular diseases 1,149 98 394 1 271 2 687 115 268
W105 1. Rheumatic heart disease 59 1 17 0 17 0 3 2 2
W106 2. Hypertensive heart disease 98 3 21 0 13 0 30 4 6
W107 3. Ischaemic heart disease 469 36 116 0 74 0 244 65 134
W108 4. Cerebrovascular disease 208 33 139 0 89 1 218 34 76
W109 5. Inflammatory heart diseases 62 2 24 0 26 0 32 7 11
W111 H. Respiratory diseases 261 12 146 1 136 1 375 16 242
W112 1. Chronic obstructive pulmonary disease 53 4 41 0 28 0 74 9 164
W113 2. Asthma 103 4 37 0 37 0 97 5 56
W115 I. Digestive diseases 371 17 150 0 144 1 203 23 65
W116 1. Peptic ulcer disease 10 0 11 0 8 0 3 3 4
W117 2. Cirrhosis of the liver 97 - 32 0 27 0 36 7 13
W118 3. Appendicitis 1 0 1 0 1 0 1 0 1
05/18/2010 + ^

9. W120 J. Genitourinary diseases 152 10 69 0 56 0 87 11 30
W121 1. Nephritis and nephrosis 111 6 33 0 38 0 45 3 8
W122 2. Benign prostatic hypertrophy 7 1 14 0 4 0 21 2 5
W124 K. Skin diseases 15 1 48 0 12 0 27 1 2
W125 L. Musculoskeletal diseases 80 22 121 0 46 0 206 18 95
W126 1. Rheumatoid arthritis 14 4 15 0 6 0 46 3 16
W127 2. Osteoarthritis 31 12 72 0 23 0 93 8 54
W131 M. Congenital anomalies 455 7 50 0 117 0 179 14 36
W143 N. Oral conditions 26 4 27 0 11 0 67 6 17
W144 1. Dental caries 19 2 17 0 8 0 55 4 10
W145 2. Periodontal disease 2 0 2 0 1 0 2 0 1
W146 3. Edentulism 5 1 8 0 3 0 10 2 6
W148 III.Injuries 1,200 88 913 1 1,088 1 736 43 211
W149 A. Unintentional injuries 902 78 537 1 784 1 463 37 151
W150 1. Road traffic accidents 301 5 185 0 284 0 148 8 49
W151 2. Poisonings 28 1 22 0 32 0 6 1 22
W152 3. Falls 114 10 30 0 42 0 36 4 22
W153 4. Fires 70 2 46 0 74 0 13 2 3
W154 5. Drownings 79 1 35 0 72 0 28 2 6
W155 6. Other unintentional injuries 310 59 220 0 279 0 232 20 50
W156 B. Intentional injuries 297 9 376 0 304 0 273 5 59
W157 1. Self-inflicted injuries 63 2 22 0 29 0 83 2 51
W158 2. Violence 49 5 184 0 218 0 188 3 8
W159 3. War 176 2 170 0 57 0 1 0 -
Refer to Notes sheet for notes on this table.
05/18/2010 + ^

10. All cause mortality (c) Level 4b Level 2b Level 3b Level 3b Level 4b Level 3b Level 1a Level 2a Level 1a
Cause-specific mortality (d) Level 4 Level 2b Level 4 Level 4 Level 4 Level 2b Level 2a Level 2a Level 2b
Population ('000) (e) 22,930 3,141 31,266 69 13,184 73 37,981 3,072 19,544
W000 All Causes 2,113.1 703.5 554.4 811.9 2,325.3 799.6 741.0 851.2 647.6
Lower uncertainty bound (f) 1,516.1 615.8 505.4 755.7 1,936.7 731.9 728.3 769.6 635.0
Upper uncertainty bound (f) 3,034.6 891.1 602.6 867.3 3,298.1 867.7 754.6 1,100.6 659.0
W001 I. Communicable, maternal, perinatal and 1,383.3 58.1 182.1 36.7 1,747.0 106.9 95.4 42.1 28.1
W002 nutritional conditions
A. Infectious and parasitic diseases 738.2 7.1 96.5 14.3 1,084.9 31.7 41.0 16.4 9.2
W003 1. Tuberculosis 92.2 0.8 1.9 1.1 36.4 - 2.2 5.4 0.3
W004 2. STDs excluding HIV 1.2 0.2 6.8 0.0 17.7 0.6 0.1 0.1 0.1
W005 a. Syphilis 0.3 0.1 6.5 0.0 17.2 0.6 0.1 0.0 0.0
W006 b. Chlamydia 0.3 - 0.1 - 0.2 - - - -
W007 c. Gonorrhoea 0.1 - 0.0 - 0.1 - - 0.0 -
W009 3. HIV/AIDS 0.0 0.3 1.0 4.0 159.9 13.7 4.7 5.7 0.6
W010 4. Diarrhoeal diseases 179.5 0.2 26.1 0.9 369.9 0.6 1.1 1.9 0.2
W011 5. Childhood-cluster diseases 67.8 0.1 13.0 0.1 93.8 0.5 0.1 0.2 0.1
W012 a. Pertussis 28.7 - 1.8 - 32.1 - 0.0 0.0 0.0
W013 b. Poliomyelitis 0.0 - - 0.0 - - - - 0.1
W014 c. Diphtheria 0.0 - 0.0 - 0.4 - - 0.1 -
W015 d. Measles 9.8 - 11.0 - 46.7 - - 0.1 -
W016 e. Tetanus 29.3 0.1 0.1 0.0 14.6 0.5 0.0 0.0 0.0
W017 6. Meningitis 36.2 1.4 0.7 0.6 4.6 4.3 1.1 0.9 0.3
W018 7. Hepatitis B (g) 4.4 0.3 1.5 0.2 6.1 0.3 0.2 0.1 0.1
W019 Hepatitis C (g) 2.1 0.1 0.7 1.3 2.7 0.2 0.3 0.0 0.0
W020 8. Malaria 4.1 - 0.0 0.0 136.1 - - 0.1 0.0
W021 9. Tropical-cluster diseases 1.6 0.1 3.1 0.0 23.2 - 1.7 - -
W022 a. Trypanosomiasis 0.0 - 2.2 - 9.9 - - - -
W023 b. Chagas disease - - - - - - 1.7 - -
W024 c. Schistosomiasis 0.0 - 0.2 - 11.6 - - - -
W025 d. Leishmaniasis 1.6 0.1 0.8 0.0 1.8 - 0.0 - -
W026 e. lymphatic filariasis 0.0 - - - - - - - -
W027 f. Onchocerciasis - - - - - - - - -
W028 10. Leprosy 0.0 - 0.3 0.0 0.1 - 0.1 - -
W029 11. Dengue 0.0 - 0.0 - 0.0 - - - 0.0
W030 12. Japanese encephalitis - - - - - - - - -
W031 13. Trachoma - - - - - - - - -
W032 14. Intestinal nematode infections 0.1 0.0 0.2 - 0.5 - 0.0 - 0.0
W033 a. Ascariasis 0.0 - 0.0 - 0.0 - - - -
W034 b. Trichuriasis - - 0.0 - 0.0 - - - -
W035 c. Hookworm disease 0.1 - 0.2 - 0.4 - - - -
W038 B. Respiratory infections 247.4 31.4 45.2 19.0 362.8 33.0 33.2 10.0 14.3
W039 1. Lower respiratory infections 243.9 31.0 44.2 18.8 356.3 33.0 33.1 9.8 14.2
W040 2. Upper respiratory infections 3.4 0.4 0.9 0.2 5.9 - 0.0 0.2 0.1
W041 3. Otitis media 0.1 - 0.0 0.0 0.7 - - 0.0 0.0
W042 C. Maternal conditions 82.0 0.6 3.3 0.0 85.6 3.2 0.9 0.3 0.1
W049 D. Perinatal conditions (h) 270.3 17.2 33.9 2.0 144.2 25.9 15.4 14.7 3.4
W050 1. Low birth weight 149.3 3.0 14.6 0.3 62.2 11.7 4.1 7.5 0.2
W051 2. Birth asphyxia and birth trauma 74.9 4.8 14.0 0.9 59.5 9.1 7.0 4.6 0.9
W053 E. Nutritional deficiencies 45.4 1.8 3.2 1.4 69.4 13.1 4.9 0.8 1.2
W054 1. Protein-energy malnutrition 31.8 0.7 1.7 0.3 62.1 2.1 3.6 0.3 0.4
W055 2. Iodine deficiency 0.7 - 0.0 - 0.2 - - - -
W056 3. Vitamin A deficiency 0.1 0.1 0.6 - 4.9 - - - -
W057 4. Iron-deficiency anaemia 5.7 0.9 0.8 0.7 2.0 11.0 1.1 0.5 0.5
W059 II. Noncommunicable diseases 613.0 583.1 300.2 735.9 387.3 658.8 592.7 769.4 578.7
W060 A. Malignant neoplasms 82.6 123.5 54.2 223.3 70.0 129.1 157.6 153.1 186.6
W061 1. Mouth and oropharynx cancers 10.1 2.2 2.5 5.4 7.4 2.2 2.7 3.1 3.7
W062 2. Oesophagus cancer 10.1 1.6 0.8 4.8 3.4 2.4 6.5 1.8 5.6
W063 3. Stomach cancer 5.4 18.2 4.5 14.7 10.4 15.1 9.0 16.3 6.6
W064 4. Colon and rectum cancers 4.2 4.0 4.2 31.8 2.6 10.9 19.4 11.5 27.2
W065 5. Liver cancer 2.8 17.6 0.5 10.9 3.9 - 4.9 8.5 4.1
W066 6. Pancreas cancer 0.7 4.4 1.4 9.9 0.9 3.8 9.5 6.1 9.2
W067 7. Trachea, bronchus, lung cancers 5.7 29.7 7.2 42.9 3.2 7.3 23.1 32.5 36.0
W068 8. Melanoma and other skin cancers 0.4 1.8 0.4 3.0 2.1 - 2.3 2.7 7.6
W069 9. Breast cancer 8.9 6.9 5.4 16.4 6.5 14.7 15.8 16.4 14.1
W070 10. Cervix uteri cancer 1.2 1.0 3.2 1.4 6.5 2.8 2.9 3.5 1.4
W071 11. Corpus uteri cancer 0.4 2.3 0.4 3.1 0.6 1.9 5.0 4.1 1.5
W072 12. Ovary cancer 1.9 0.6 1.1 3.8 1.3 1.6 3.1 4.7 4.0
W073 13. Prostate cancer 1.2 7.1 2.4 14.2 4.2 31.1 11.6 3.3 15.4
W074 14. Bladder cancer 2.8 - 4.5 9.8 2.5 3.4 4.0 3.8 4.7
W075 15. Lymphomas, multiple myeloma 8.2 3.0 4.0 12.3 4.3 8.9 6.9 4.8 13.8
W076 16. Leukaemia 5.8 4.9 1.2 7.8 1.4 5.1 5.8 4.9 7.7
W078 B. Other neoplasms 9.4 10.1 0.9 7.7 1.8 2.9 6.3 0.3 4.0
W079 C. Diabetes mellitus 11.8 6.2 9.7 19.9 12.4 54.3 25.4 50.7 16.3
W080 D. Endocrine disorders 14.2 1.9 2.5 5.6 5.0 35.8 7.3 2.3 7.3
W081 E. Neuropsychiatric conditions 38.2 18.2 8.5 65.6 18.5 23.0 15.1 8.5 38.1
W082 1. Unipolar depressive disorders 0.0 0.1 - 0.2 - - 0.0 0.0 0.3
W083 2. Bipolar disorder - - - 0.1 - - - 0.0 0.0
W084 3. Schizophrenia 0.1 0.5 - 0.2 - - 0.0 0.3 0.2
W085 4. Epilepsy 3.4 3.8 3.5 0.7 8.2 3.6 0.7 1.7 1.3
W086 5. Alcohol use disorders 0.5 0.0 0.8 0.6 1.3 11.7 1.9 0.7 1.4
W087 6. Alzheimer and other dementias* 0.6 1.4 1.0 50.0 1.0 0.5 5.9 2.1 20.3
W088 7. Parkinson disease 0.2 1.4 0.9 5.2 0.7 - 1.6 1.0 4.5
W089 8. Multiple sclerosis 0.2 1.4 0.0 0.4 0.1 0.7 0.3 0.3 0.6
W090 9. Drug use disorders 22.9 0.7 0.2 1.4 0.2 0.1 0.6 0.7 2.8
W091 10. Post-traumatic stress disorder - 0.1 - - - - - 0.0 -
W092 11. Obsessive-compulsive disorder - - - - - - - - -
W093 12. Panic disorder - - - - - - - - -
W094 13. Insomnia (primary) - - - - - - - - -
W095 14. Migraine - - - - - - - - -
W098 F. Sense organ diseases 0.4 0.3 - 0.0 - - - - 0.0
W099 1. Glaucoma - - - 0.0 - - - - -
W100 2. Cataracts - - - - - - - - -
W101 3. Vision disorders, age-related - - - - - - - - -
W102 4. Hearing loss, adult onset - - - - - - - - -
W104 G. Cardiovascular diseases 295.0 366.4 150.0 269.5 167.2 317.7 245.5 461.4 241.7
W105 1. Rheumatic heart disease 8.5 1.4 2.4 3.9 4.7 - 0.6 4.9 1.2
W106 2. Hypertensive heart disease 32.6 14.1 8.0 11.7 8.9 33.7 11.9 16.6 5.9
W107 3. Ischaemic heart disease 144.6 127.0 47.8 97.5 54.1 71.9 90.3 277.2 130.3
W108 4. Cerebrovascular disease 50.3 132.7 51.9 75.9 58.0 127.3 59.7 137.1 60.0
W109 5. Inflammatory heart diseases 10.2 3.6 5.0 9.9 8.2 0.5 8.2 18.9 4.9
W111 H. Respiratory diseases 37.6 21.0 34.8 71.9 46.0 12.1 73.0 35.9 39.6
W112 1. Chronic obstructive pulmonary disease 14.2 8.8 16.1 36.6 17.6 1.9 13.4 25.5 26.7
W113 2. Asthma 10.0 8.5 1.8 2.0 2.5 0.3 2.2 4.0 2.2
W115 I. Digestive diseases 54.1 16.1 19.1 42.9 30.2 36.9 31.4 33.1 21.5
W116 1. Peptic ulcer disease 2.0 1.1 2.0 1.4 2.7 0.6 1.1 5.0 2.5
W117 2. Cirrhosis of the liver 24.2 - 6.6 13.4 10.6 18.1 6.9 16.1 4.7
05/18/2010 + ^

11. W118 3. Appendicitis 0.1 0.1 0.1 0.2 0.3 0.7 0.2 0.4 0.1
W120 J. Genitourinary diseases 30.6 13.4 11.5 17.5 20.3 25.8 19.7 14.2 14.3
W121 1. Nephritis and nephrosis 27.7 11.8 10.5 13.8 19.3 24.1 16.9 7.5 10.7
W122 2. Benign prostatic hypertrophy 0.5 0.6 0.4 0.3 0.3 - 0.1 1.9 0.2
W124 K. Skin diseases 0.8 0.2 6.4 1.6 0.0 12.9 1.6 0.3 1.3
W125 L. Musculoskeletal diseases 0.8 1.3 0.3 7.8 2.2 3.3 1.5 2.2 4.6
W126 1. Rheumatoid arthritis 0.1 0.4 0.1 0.6 0.3 - 0.3 0.4 1.0
W127 2. Osteoarthritis 0.0 0.1 - 0.3 - - 0.1 0.0 0.6
W131 M. Congenital anomalies 37.5 4.5 2.2 2.3 13.7 5.1 8.2 7.3 3.2
W143 N. Oral conditions 0.1 0.0 - 0.0 - - - - 0.1
W144 1. Dental caries - - - - - - - - -
W145 2. Periodontal disease - - - - - - - - -
W146 3. Edentulism - - - - - - - - -
W148 III.Injuries 116.7 62.3 72.1 39.3 191.0 33.9 52.9 39.6 40.7
W149 A. Unintentional injuries 79.3 53.5 41.2 31.2 130.8 23.2 33.8 32.5 27.9
W150 1. Road traffic accidents 36.7 2.5 17.2 15.2 58.0 10.8 11.5 10.6 8.6
W151 2. Poisonings 4.4 1.3 3.1 2.8 9.1 0.6 0.5 2.4 4.2
W152 3. Falls 5.6 0.7 2.4 3.7 5.2 - 1.0 1.4 3.3
W153 4. Fires 5.3 0.3 3.9 0.3 11.6 0.4 1.3 1.6 0.5
W154 5. Drownings 10.3 1.2 3.7 0.9 17.9 3.2 2.5 2.2 1.2
W155 6. Other unintentional injuries 17.1 47.4 10.8 8.3 28.9 8.1 17.0 14.2 10.1
W156 B. Intentional injuries 37.4 8.9 30.9 8.1 60.2 10.7 19.1 7.2 12.8
W157 1. Self-inflicted injuries 6.5 2.6 2.9 7.2 8.1 0.5 10.2 3.4 11.3
W158 2. Violence 4.0 6.0 12.0 0.9 39.6 10.2 8.8 3.7 1.5
W159 3. War 25.7 0.1 16.1 - 12.5 - - 0.2 -
Refer to Notes sheet for notes on this table.
05/18/2010 + ^

12. All cause mortality (c) Level 4b Level 2b Level 3b Level 3b Level 4b Level 3b Level 1a Level 2a Level 1a
Cause-specific mortality (d) Level 4 Level 2b Level 4 Level 4 Level 4 Level 2b Level 2a Level 2a Level 2b
Incidence, prevalence, severity, duration (j) Level 4 Level 3 Level 4 Level 4 Level 4 Level 3 Level 3 Level 3 Level 3
Population ('000) (e) 22,930 3,141 31,266 69 13,184 73 37,981 3,072 19,544
W000 All Causes 74,186 16,006 17,590 12,356 81,592 18,309 16,570 16,804 11,021
W001 I. Communicable, maternal, perinatal and 51,061 2,221 6,603 643 61,999 2,825 2,065 2,067 562
W002 nutritional conditions
A. Infectious and parasitic diseases 25,354 304 3,355 302 37,073 1,145 901 674 177
W003 1. Tuberculosis 2,279 20 64 14 1,008 2 47 148 3
W004 2. STDs excluding HIV 228 56 433 21 753 107 97 94 21
W005 a. Syphilis 12 2 141 1 466 17 11 3 1
W006 b. Chlamydia 96 35 126 16 112 50 49 65 16
W007 c. Gonorrhoea 113 17 163 4 170 39 37 25 4
W009 3. HIV/AIDS 1 8 30 136 4,865 428 169 158 22
W010 4. Diarrhoeal diseases 5,857 37 945 26 12,197 132 130 114 27
W011 5. Childhood-cluster diseases 2,552 21 495 14 3,590 36 31 21 25
W012 a. Pertussis 1,229 21 101 13 1,446 31 30 13 25
W013 b. Poliomyelitis 4 - 2 0 4 1 1 3 0
W014 c. Diphtheria 0 - 1 - 14 0 0 0 -
W015 d. Measles 347 0 387 - 1,639 0 0 5 -
W016 e. Tetanus 971 0 3 0 488 5 0 0 0
W017 6. Meningitis 2,003 44 17 20 223 207 37 18 14
W018 7. Hepatitis B (g) 115 6 24 3 182 3 3 3 1
W019 Hepatitis C (g) 57 3 11 10 82 2 3 1 1
W020 8. Malaria 280 - 0 0 5,165 - 1 17 0
W021 9. Tropical-cluster diseases 74 3 337 0 1,105 111 98 8 -
W022 a. Trypanosomiasis 0 - 78 - 308 - - - -
W023 b. Chagas disease - - - - - 77 92 - -
W024 c. Schistosomiasis 0 - 210 - 363 28 - - -
W025 d. Leishmaniasis 74 3 50 0 83 6 6 8 -
W026 e. lymphatic filariasis 1 - - - 338 - - - -
W027 f. Onchocerciasis - - - - 13 - - - -
W028 10. Leprosy 6 0 4 0 4 2 3 - 0
W029 11. Dengue 1 - 0 - 1 - - - 0
W030 12. Japanese encephalitis 4 - - - - - - - -
W031 13. Trachoma 23 - - - 31 - - - 1
W032 14. Intestinal nematode infections 57 0 244 - 305 16 16 0 0
W033 a. Ascariasis 25 - 186 - 241 3 3 0 -
W034 b. Trichuriasis 21 - 19 - 26 9 9 - -
W035 c. Hookworm disease 11 - 38 - 37 4 3 0 -
W038 B. Respiratory infections 9,014 630 1,008 87 12,393 211 253 266 66
W039 1. Lower respiratory infections 8,857 602 968 75 12,127 186 229 239 52
W040 2. Upper respiratory infections 121 13 14 4 210 3 4 9 4
W041 3. Otitis media 36 15 27 7 56 22 21 18 11
W042 C. Maternal conditions 4,109 146 464 54 3,787 255 139 143 46
W049 D. Perinatal conditions (h) 10,394 685 1,304 127 5,574 1,089 649 660 204
W050 1. Low birth weight 5,560 145 521 33 2,227 420 156 263 48
W051 2. Birth asphyxia and birth trauma 3,212 220 596 57 2,545 487 343 299 67
W053 E. Nutritional deficiencies 2,191 457 471 75 3,172 126 122 324 69
W054 1. Protein-energy malnutrition 1,475 63 161 5 2,615 18 75 23 1
W055 2. Iodine deficiency 57 299 37 - 59 - 2 14 -
W056 3. Vitamin A deficiency 4 2 9 - 167 - - 1 -
W057 4. Iron-deficiency anaemia 411 77 264 68 324 106 43 285 66
W059 II. Noncommunicable diseases 17,892 10,989 8,066 10,684 11,341 14,024 12,568 13,351 9,381
W060 A. Malignant neoplasms 1,540 1,443 557 1,862 889 1,196 1,488 1,847 1,568
W061 1. Mouth and oropharynx cancers 171 24 33 57 71 21 29 32 36
W062 2. Oesophagus cancer 154 13 7 46 41 9 50 15 40
W063 3. Stomach cancer 90 191 43 107 125 139 76 177 47
W064 4. Colon and rectum cancers 82 54 41 246 31 84 149 119 238
W065 5. Liver cancer 46 158 4 72 53 - 39 86 33
W066 6. Pancreas cancer 12 44 12 72 13 25 73 59 64
W067 7. Trachea, bronchus, lung cancers 73 281 64 361 37 59 213 328 265
W068 8. Melanoma and other skin cancers 7 20 4 27 24 0 22 25 69
W069 9. Breast cancer 164 117 72 182 79 209 166 235 174
W070 10. Cervix uteri cancer 20 20 42 20 87 46 51 62 21
W071 11. Corpus uteri cancer 10 70 3 46 8 35 80 83 22
W072 12. Ovary cancer 40 15 13 37 20 18 35 66 39
W073 13. Prostate cancer 9 50 13 76 25 148 61 26 92
W074 14. Bladder cancer 31 - 30 66 25 27 28 32 30
W075 15. Lymphomas, multiple myeloma 207 46 58 101 90 93 73 85 105
W076 16. Leukaemia 175 93 22 69 24 93 80 88 68
W078 B. Other neoplasms 180 112 12 48 38 38 65 5 23
W079 C. Diabetes mellitus 214 152 156 324 156 569 385 616 237
W080 D. Endocrine disorders 330 147 96 185 289 1,556 210 197 223
W081 E. Neuropsychiatric conditions 3,712 3,159 2,358 3,553 2,676 4,039 4,559 2,959 3,064
W082 1. Unipolar depressive disorders 1,256 1,176 727 1,034 612 1,236 1,203 1,245 958
W083 2. Bipolar disorder 228 208 281 169 240 223 216 234 166
W084 3. Schizophrenia 268 251 279 155 234 266 258 290 165
W085 4. Epilepsy 185 144 148 45 299 176 145 84 57
W086 5. Alcohol use disorders 12 154 19 650 123 780 1,216 105 369
W087 6. Alzheimer and other dementias* 54 138 57 546 54 169 237 191 417
W088 7. Parkinson disease 41 50 12 83 11 8 16 43 84
W089 8. Multiple sclerosis 22 30 19 32 17 21 23 27 26
W090 9. Drug use disorders 620 103 78 146 63 103 248 47 243
W091 10. Post-traumatic stress disorder 51 59 55 54 45 46 44 61 54
W092 11. Obsessive-compulsive disorder 60 127 130 68 123 121 119 125 43
W093 12. Panic disorder 114 108 126 88 109 107 105 114 86
W094 13. Insomnia (primary) 59 59 54 86 42 74 74 34 82
W095 14. Migraine 147 121 61 199 62 161 151 113 114
W098 F. Sense organ diseases 974 580 1,677 577 1,278 907 1,041 1,043 404
W099 1. Glaucoma 10 33 175 24 135 55 63 52 6
W100 2. Cataracts 460 53 967 25 741 289 335 94 6
W101 3. Vision disorders, age-related 73 201 171 89 130 278 324 380 63
W102 4. Hearing loss, adult onset 425 289 364 439 272 285 318 516 328
W104 G. Cardiovascular diseases 5,010 3,104 1,259 1,493 2,052 2,557 1,810 3,737 1,369
W105 1. Rheumatic heart disease 256 26 53 27 129 4 7 72 12
W106 2. Hypertensive heart disease 428 85 67 52 98 206 78 128 29
W107 3. Ischaemic heart disease 2,044 1,145 370 534 560 547 643 2,125 687
W108 4. Cerebrovascular disease 908 1,058 444 494 673 1,127 573 1,121 391
W109 5. Inflammatory heart diseases 272 52 75 80 196 17 83 226 58
W111 H. Respiratory diseases 1,137 374 465 1,090 1,032 704 986 536 1,238
W112 1. Chronic obstructive pulmonary disease 230 136 130 413 209 246 194 290 838
W113 2. Asthma 449 138 120 159 281 294 256 159 289
W115 I. Digestive diseases 1,618 531 480 634 1,089 884 534 761 334
W116 1. Peptic ulcer disease 43 12 35 21 62 12 9 88 18
W117 2. Cirrhosis of the liver 425 - 102 194 202 337 94 218 68
W118 3. Appendicitis 5 4 4 4 10 7 4 7 3
05/18/2010 + ^

13. W120 J. Genitourinary diseases 664 317 220 147 426 363 228 343 153
W121 1. Nephritis and nephrosis 482 184 106 59 292 248 120 101 43
W122 2. Benign prostatic hypertrophy 29 23 45 28 34 48 54 68 27
W124 K. Skin diseases 66 22 153 21 92 124 72 46 12
W125 L. Musculoskeletal diseases 350 707 387 521 347 543 541 584 488
W126 1. Rheumatoid arthritis 61 137 48 100 42 118 121 85 83
W127 2. Osteoarthritis 137 390 231 279 178 212 244 268 278
W131 M. Congenital anomalies 1,986 221 160 142 890 366 471 468 183
W143 N. Oral conditions 112 120 86 88 87 179 177 209 87
W144 1. Dental caries 83 73 54 47 62 152 145 133 52
W145 2. Periodontal disease 7 5 6 4 4 5 5 4 4
W146 3. Edentulism 20 41 24 36 19 21 25 69 30
W148 III.Injuries 5,233 2,796 2,921 1,028 8,251 1,459 1,937 1,385 1,077
W149 A. Unintentional injuries 3,936 2,495 1,718 865 5,944 1,003 1,218 1,219 774
W150 1. Road traffic accidents 1,315 160 590 399 2,157 404 390 276 250
W151 2. Poisonings 124 38 69 79 245 9 15 37 113
W152 3. Falls 496 325 95 129 317 72 95 136 112
W153 4. Fires 305 62 148 9 562 21 34 66 13
W154 5. Drownings 343 38 113 16 544 63 74 57 31
W155 6. Other unintentional injuries 1,354 1,873 703 234 2,119 435 611 647 255
W156 B. Intentional injuries 1,297 301 1,203 163 2,307 456 719 166 303
W157 1. Self-inflicted injuries 276 67 70 133 220 21 219 62 262
W158 2. Violence 213 175 590 29 1,654 431 494 100 41
W159 3. War 770 54 543 0 433 5 2 4 -
Refer to Notes sheet for notes on this table.
05/18/2010 + ^

14. All cause mortality (c) Level 4b Level 2b Level 3b Level 3b Level 4b Level 3b Level 1a Level 2a Level 1a
Cause-specific mortality (d) Level 4 Level 2b Level 4 Level 4 Level 4 Level 2b Level 2a Level 2a Level 2b
Population ('000) (e) 22,930 3,141 31,266 69 13,184 73 37,981 3,072 19,544
W000 All Causes 2,333.2 948.0 911.4 422.6 2,518.2 858.6 658.7 905.2 417.0
Lower uncertainty bound (f) 1,674.1 829.8 830.8 393.4 2,097.5 785.9 647.4 818.4 408.9
Upper uncertainty bound (f) 3,350.8 1,200.8 990.7 451.5 3,571.8 931.6 670.7 1,170.4 424.4
W001 I. Communicable, maternal, perinatal and 930.4 70.4 228.4 22.6 1,305.8 107.2 85.4 66.0 19.6
W002 nutritional conditions
A. Infectious and parasitic diseases 535.6 8.1 124.2 9.3 861.0 32.4 37.2 18.8 6.0
W003 1. Tuberculosis 141.0 1.0 2.3 0.6 56.3 - 2.1 5.2 0.2
W004 2. STDs excluding HIV 2.1 0.2 10.1 0.0 23.9 0.7 0.1 0.2 0.0
W005 a. Syphilis 0.5 0.2 9.7 0.0 23.2 0.7 0.1 0.1 0.0
W006 b. Chlamydia 0.4 - 0.1 - 0.2 - - - -
W007 c. Gonorrhoea 0.2 - 0.1 - 0.2 - - 0.0 -
W009 3. HIV/AIDS 0.0 0.3 1.2 3.6 199.1 14.1 5.0 5.5 0.5
W010 4. Diarrhoeal diseases 135.7 0.2 24.3 0.4 234.0 0.6 1.0 3.5 0.1
W011 5. Childhood-cluster diseases 34.3 0.1 10.8 0.0 41.5 0.6 0.1 0.3 0.1
W012 a. Pertussis 13.5 - 1.6 - 13.4 - 0.0 0.1 0.0
W013 b. Poliomyelitis 0.0 - - 0.0 - - - - 0.0
W014 c. Diphtheria 0.0 - 0.0 - 0.2 - - 0.0 -
W015 d. Measles 5.0 - 9.2 - 21.3 - - 0.2 -
W016 e. Tetanus 15.8 0.1 0.1 0.0 6.7 0.6 0.0 0.0 0.0
W017 6. Meningitis 19.7 1.5 1.0 0.6 3.9 4.2 1.1 0.9 0.3
W018 7. Hepatitis B (g) 5.7 0.3 2.3 0.2 6.8 0.4 0.2 0.1 0.1
W019 Hepatitis C (g) 2.8 0.1 1.1 0.7 3.1 0.2 0.3 0.0 0.0
W020 8. Malaria 2.2 - 0.0 0.0 76.8 - - 0.1 0.0
W021 9. Tropical-cluster diseases 1.2 0.1 3.3 0.0 37.9 - 1.6 - -
W022 a. Trypanosomiasis 0.0 - 2.2 - 11.1 - - - -
W023 b. Chagas disease - - - - - - 1.6 - -
W024 c. Schistosomiasis 0.0 - 0.3 - 25.1 - - - -
W025 d. Leishmaniasis 1.1 0.1 0.7 0.0 1.7 - 0.0 - -
W026 e. lymphatic filariasis 0.0 - - - - - - - -
W027 f. Onchocerciasis - - - - - - - - -
W028 10. Leprosy 0.0 - 0.6 0.0 0.3 - 0.1 - -
W029 11. Dengue 0.0 - 0.0 - 0.0 - - - 0.0
W030 12. Japanese encephalitis - - - - - - - - -
W031 13. Trachoma - - - - - - - - -
W032 14. Intestinal nematode infections 0.1 0.1 0.3 - 1.0 - 0.0 - 0.0
W033 a. Ascariasis 0.0 - 0.0 - 0.0 - - - -
W034 b. Trichuriasis - - 0.0 - 0.0 - - - -
W035 c. Hookworm disease 0.0 - 0.3 - 0.9 - - - -
W038 B. Respiratory infections 150.4 41.3 66.6 8.6 220.0 33.8 28.1 16.0 7.9
W039 1. Lower respiratory infections 148.5 40.9 65.0 8.5 215.4 33.8 28.0 15.6 7.8
W040 2. Upper respiratory infections 1.9 0.5 1.5 0.1 4.0 - 0.0 0.3 0.0
W041 3. Otitis media 0.1 - 0.0 0.0 0.6 - - 0.0 0.0
W042 C. Maternal conditions 93.5 0.6 3.2 0.0 106.4 3.1 0.9 0.2 0.1
W049 D. Perinatal conditions (h) 126.7 18.4 28.6 4.1 59.4 24.3 15.0 30.2 5.0
W050 1. Low birth weight 69.8 3.2 12.3 0.5 25.6 11.0 4.0 15.5 0.3
W051 2. Birth asphyxia and birth trauma 35.2 5.2 11.8 1.7 24.5 8.5 6.8 9.4 1.3
W053 E. Nutritional deficiencies 24.2 1.9 5.9 0.6 59.0 13.6 4.2 0.7 0.7
W054 1. Protein-energy malnutrition 16.1 0.7 3.1 0.1 54.4 2.2 3.1 0.3 0.2
W055 2. Iodine deficiency 0.4 - 0.1 - 0.1 - - - -
W056 3. Vitamin A deficiency 0.1 0.1 1.1 - 3.0 - - - -
W057 4. Iron-deficiency anaemia 3.9 1.0 1.5 0.3 1.3 11.4 0.9 0.4 0.3
W059 II. Noncommunicable diseases 1,268.7 813.5 597.6 369.0 981.7 716.7 521.1 800.3 362.2
W060 A. Malignant neoplasms 152.7 154.2 103.1 126.2 179.4 143.8 142.3 146.0 126.9
W061 1. Mouth and oropharynx cancers 19.5 2.9 4.5 3.6 21.4 2.6 2.5 2.8 2.7
W062 2. Oesophagus cancer 20.3 2.2 1.5 3.1 8.4 2.5 5.8 1.7 3.8
W063 3. Stomach cancer 10.9 23.2 8.7 8.1 27.0 17.5 8.1 15.7 4.4
W064 4. Colon and rectum cancers 7.6 4.9 8.1 16.8 7.1 12.4 16.9 10.6 18.3
W065 5. Liver cancer 5.2 22.7 1.1 5.8 9.5 - 4.3 7.9 2.9
W066 6. Pancreas cancer 1.4 5.4 2.8 5.5 1.8 4.2 8.4 5.7 6.1
W067 7. Trachea, bronchus, lung cancers 12.3 37.3 13.9 25.9 7.9 8.4 21.4 30.5 24.8
W068 8. Melanoma and other skin cancers 0.7 2.3 0.8 1.7 5.7 - 2.1 2.8 5.2
W069 9. Breast cancer 16.3 8.2 9.7 9.7 17.3 16.9 14.6 15.8 10.0
W070 10. Cervix uteri cancer 2.4 1.2 5.8 0.9 15.8 3.1 3.0 3.5 1.1
W071 11. Corpus uteri cancer 0.9 2.6 0.7 1.6 1.9 2.1 4.6 4.1 1.0
W072 12. Ovary cancer 3.3 0.7 2.1 2.2 2.9 1.8 2.9 4.4 2.8
W073 13. Prostate cancer 3.5 9.9 4.9 6.4 14.5 33.4 9.5 3.2 9.2
W074 14. Bladder cancer 7.7 - 9.4 5.0 7.4 3.7 3.4 3.5 2.9
W075 15. Lymphomas, multiple myeloma 11.4 3.5 6.9 6.9 8.5 9.8 6.3 4.7 9.2
W076 16. Leukaemia 6.3 5.4 2.0 4.6 3.0 5.3 5.3 5.3 5.4
W078 B. Other neoplasms 16.5 12.7 1.7 4.0 3.2 3.1 5.7 0.3 2.5
W079 C. Diabetes mellitus 28.4 7.9 18.9 9.3 32.4 59.5 22.1 46.8 10.4
W080 D. Endocrine disorders 25.8 2.1 4.3 3.3 8.2 36.3 6.4 2.3 5.0
W081 E. Neuropsychiatric conditions 57.2 23.4 14.1 29.8 28.6 25.1 13.5 9.3 23.9
W082 1. Unipolar depressive disorders 0.0 0.1 - 0.1 - - 0.0 0.0 0.2
W083 2. Bipolar disorder - - - 0.0 - - - 0.0 0.0
W084 3. Schizophrenia 0.2 0.5 - 0.1 - - 0.0 0.3 0.1
W085 4. Epilepsy 3.6 3.9 5.1 0.4 11.8 3.7 0.7 1.8 1.1
W086 5. Alcohol use disorders 0.6 0.1 1.2 0.4 2.7 13.4 1.9 0.7 1.1
W087 6. Alzheimer and other dementias* 2.5 2.1 2.2 20.6 3.2 0.6 4.8 2.4 10.6
W088 7. Parkinson disease 0.6 2.0 2.0 2.2 2.7 - 1.3 1.2 2.5
W089 8. Multiple sclerosis 0.5 2.2 0.0 0.3 0.1 0.7 0.3 0.3 0.5
W090 9. Drug use disorders 32.4 0.7 0.3 1.3 0.3 0.1 0.7 0.8 2.8
W091 10. Post-traumatic stress disorder - 0.1 - - - - - 0.0 -
W092 11. Obsessive-compulsive disorder - - - - - - - - -
W093 12. Panic disorder - - - - - - - - -
W094 13. Insomnia (primary) - - - - - - - - -
W095 14. Migraine - - - - - - - - -
W098 F. Sense organ diseases 1.6 0.4 - 0.0 - - - - 0.0
W099 1. Glaucoma - - - 0.0 - - - - -
W100 2. Cataracts - - - - - - - - -
W101 3. Vision disorders, age-related - - - - - - - - -
W102 4. Hearing loss, adult onset - - - - - - - - -
W104 G. Cardiovascular diseases 705.7 536.6 313.6 125.3 485.8 343.1 212.2 498.0 140.3
W105 1. Rheumatic heart disease 11.1 1.8 3.4 2.0 7.2 - 0.6 4.7 0.8
W106 2. Hypertensive heart disease 89.4 21.8 16.8 5.0 26.1 36.2 10.2 17.8 3.3
W107 3. Ischaemic heart disease 354.9 173.7 98.9 47.7 156.8 80.2 78.8 304.7 77.2
W108 4. Cerebrovascular disease 118.6 198.2 107.3 34.2 168.7 137.2 52.2 143.9 33.4
W109 5. Inflammatory heart diseases 24.1 5.4 9.6 5.3 16.9 0.5 7.2 19.7 3.5
W111 H. Respiratory diseases 78.8 30.4 69.2 33.0 114.1 12.7 62.9 36.3 24.3
W112 1. Chronic obstructive pulmonary disease 39.9 13.2 33.8 16.5 52.5 2.0 11.4 25.9 16.4
W113 2. Asthma 13.3 12.0 3.4 1.0 5.9 0.3 2.0 4.0 1.6
W115 I. Digestive diseases 113.6 21.6 34.3 23.0 65.0 42.6 28.5 31.5 13.5
W116 1. Peptic ulcer disease 4.5 1.8 3.9 0.7 6.6 0.7 0.9 4.7 1.5
W117 2. Cirrhosis of the liver 51.3 - 11.8 8.6 23.8 21.0 6.7 15.1 3.6
05/18/2010 + ^

15. W118 3. Appendicitis 0.2 0.1 0.2 0.1 0.5 0.8 0.1 0.4 0.1
W120 J. Genitourinary diseases 65.3 17.4 23.3 7.8 54.1 28.6 16.9 13.8 8.0
W121 1. Nephritis and nephrosis 58.3 14.8 21.1 6.2 50.9 26.9 14.5 7.3 6.0
W122 2. Benign prostatic hypertrophy 1.6 1.1 0.9 0.1 1.2 - 0.1 1.9 0.1
W124 K. Skin diseases 1.6 0.3 12.8 0.7 0.1 13.5 1.4 0.2 0.7
W125 L. Musculoskeletal diseases 1.5 1.7 0.5 3.3 4.7 3.7 1.4 2.2 2.8
W126 1. Rheumatoid arthritis 0.4 0.5 0.1 0.3 0.9 - 0.3 0.5 0.6
W127 2. Osteoarthritis 0.1 0.1 - 0.1 - - 0.0 0.0 0.3
W131 M. Congenital anomalies 19.8 4.8 1.9 3.3 6.3 4.8 8.0 13.6 4.0
W143 N. Oral conditions 0.1 0.0 - 0.0 - - - - 0.0
W144 1. Dental caries - - - - - - - - -
W145 2. Periodontal disease - - - - - - - - -
W146 3. Edentulism - - - - - - - - -
W148 III.Injuries 134.1 64.1 85.4 31.0 230.8 34.6 52.2 38.9 35.2
W149 A. Unintentional injuries 85.1 55.0 50.2 24.7 148.8 23.3 33.0 31.9 23.3
W150 1. Road traffic accidents 41.0 2.6 20.7 13.8 65.6 10.4 11.7 9.7 8.3
W151 2. Poisonings 5.2 1.3 4.2 2.6 12.9 0.7 0.5 2.5 4.2
W152 3. Falls 6.3 0.8 4.4 2.2 7.7 - 0.9 1.4 2.1
W153 4. Fires 5.5 0.3 4.5 0.3 9.6 0.4 1.2 1.7 0.4
W154 5. Drownings 8.9 1.2 3.8 0.7 19.2 3.5 2.5 2.3 1.3
W155 6. Other unintentional injuries 18.1 48.9 12.5 5.2 33.8 8.3 16.2 14.2 6.9
W156 B. Intentional injuries 49.0 9.1 35.2 6.2 82.0 11.3 19.2 7.0 11.9
W157 1. Self-inflicted injuries 6.9 2.8 3.8 5.5 11.9 0.5 10.2 3.2 10.4
W158 2. Violence 4.7 6.0 13.1 0.8 51.1 10.8 8.9 3.6 1.4
W159 3. War 36.1 0.1 18.3 - 19.0 - - 0.2 -
Refer to Notes sheet for notes on this table.
05/18/2010 + ^

16. All cause mortality (c) Level 4b Level 2b Level 3b Level 3b Level 4b Level 3b Level 1a Level 2a Level 1a
Cause-specific mortality (d) Level 4 Level 2b Level 4 Level 4 Level 4 Level 2b Level 2a Level 2a Level 2b
Incidence, prevalence, severity, duration (j) Level 4 Level 3 Level 4 Level 4 Level 4 Level 3 Level 3 Level 3 Level 3
Population ('000) (e) 22,930 3,141 31,266 69 13,184 73 37,981 3,072 19,544
W000 All Causes 57,716 15,679 18,045 10,247 62,229 17,900 15,691 16,505 9,656
W001 I. Communicable, maternal, perinatal and 31,504 2,179 5,890 746 39,359 2,688 1,966 2,843 638
W002 nutritional conditions
A. Infectious and parasitic diseases 15,416 295 3,063 306 24,113 1,108 875 744 184
W003 1. Tuberculosis 2,658 21 66 11 1,250 2 46 137 2
W004 2. STDs excluding HIV 211 53 414 22 802 104 97 90 23
W005 a. Syphilis 12 2 162 1 539 19 11 3 1
W006 b. Chlamydia 94 33 106 17 112 48 48 60 18
W007 c. Gonorrhoea 94 16 143 4 146 37 37 25 4
W009 3. HIV/AIDS 1 8 31 129 5,445 427 181 150 21
W010 4. Diarrhoeal diseases 3,157 36 803 31 5,832 125 126 168 30
W011 5. Childhood-cluster diseases 1,329 21 409 26 1,648 35 30 33 35
W012 a. Pertussis 624 21 84 25 649 29 28 23 35
W013 b. Poliomyelitis 4 - 2 0 2 1 1 3 0
W014 c. Diphtheria 0 - 1 - 6 0 0 0 -
W015 d. Measles 182 0 319 - 762 0 0 8 -
W016 e. Tetanus 519 0 3 0 229 5 0 0 0
W017 6. Meningitis 1,089 43 18 29 158 192 36 19 17
W018 7. Hepatitis B (g) 117 6 30 2 176 4 3 2 1
W019 Hepatitis C (g) 57 3 13 7 79 2 3 1 1
W020 8. Malaria 191 - 0 1 2,555 - 1 19 0
W021 9. Tropical-cluster diseases 56 3 312 0 1,227 108 97 9 -
W022 a. Trypanosomiasis 0 - 72 - 291 - - - -
W023 b. Chagas disease - - - - - 75 92 - -
W024 c. Schistosomiasis 0 - 197 - 507 27 - - -
W025 d. Leishmaniasis 56 3 43 0 71 6 6 9 -
W026 e. lymphatic filariasis 1 - - - 343 - - - -
W027 f. Onchocerciasis - - - - 16 - - - -
W028 10. Leprosy 5 0 5 0 7 2 3 - 0
W029 11. Dengue 0 - 0 - 1 - - - 0
W030 12. Japanese encephalitis 3 - - - - - - - -
W031 13. Trachoma 36 - - - 56 - - - 0
W032 14. Intestinal nematode infections 41 0 194 - 202 15 15 0 0
W033 a. Ascariasis 16 - 142 - 143 3 3 0 -
W034 b. Trichuriasis 13 - 15 - 16 8 8 - -
W035 c. Hookworm disease 11 - 37 - 43 4 4 0 -
W038 B. Respiratory infections 5,236 616 907 67 6,665 189 218 419 53
W039 1. Lower respiratory infections 5,147 590 872 49 6,494 165 194 387 35
W040 2. Upper respiratory infections 67 13 14 5 134 3 4 11 4
W041 3. Otitis media 22 13 21 13 37 20 20 21 14
W042 C. Maternal conditions 4,335 138 409 55 4,338 247 140 131 49
W049 D. Perinatal conditions (h) 5,264 686 1,091 239 2,495 1,031 619 1,198 283
W050 1. Low birth weight 2,816 145 436 61 997 398 148 478 67
W051 2. Birth asphyxia and birth trauma 1,627 221 499 106 1,139 461 327 543 94
W053 E. Nutritional deficiencies 1,253 443 421 80 1,749 112 114 350 70
W054 1. Protein-energy malnutrition 775 63 139 7 1,355 19 69 37 1
W055 2. Iodine deficiency 31 288 30 - 29 - 1 22 -
W056 3. Vitamin A deficiency 3 2 10 - 93 - - 1 -
W057 4. Iron-deficiency anaemia 314 75 241 71 268 92 41 290 67
W059 II. Noncommunicable diseases 21,325 10,813 9,432 8,454 14,844 13,809 11,794 12,280 7,911
W060 A. Malignant neoplasms 2,057 1,459 742 1,265 1,530 1,174 1,362 1,664 1,145
W061 1. Mouth and oropharynx cancers 249 24 44 43 127 20 28 28 27
W062 2. Oesophagus cancer 238 13 9 34 77 4 44 12 29
W063 3. Stomach cancer 133 193 58 69 235 138 69 154 34
W064 4. Colon and rectum cancers 114 54 56 153 56 73 128 98 170
W065 5. Liver cancer 65 158 6 43 91 - 34 73 25
W066 6. Pancreas cancer 19 44 16 45 26 23 62 51 43
W067 7. Trachea, bronchus, lung cancers 120 287 93 249 72 63 198 284 183
W068 8. Melanoma and other skin cancers 9 20 6 20 45 0 21 21 52
W069 9. Breast cancer 254 123 100 131 149 232 158 213 137
W070 10. Cervix uteri cancer 31 20 59 16 158 44 54 57 17
W071 11. Corpus uteri cancer 12 73 4 32 13 37 79 77 17
W072 12. Ovary cancer 54 15 18 26 33 17 32 59 29
W073 13. Prostate cancer 15 44 16 36 44 125 43 20 54
W074 14. Bladder cancer 51 - 41 38 48 27 23 25 19
W075 15. Lymphomas, multiple myeloma 223 46 66 69 113 97 67 85 76
W076 16. Leukaemia 159 90 22 54 33 86 76 100 55
W078 B. Other neoplasms 239 116 15 34 41 38 61 5 17
W079 C. Diabetes mellitus 327 152 206 222 277 539 349 511 184
W080 D. Endocrine disorders 370 146 115 188 298 1,540 197 198 211
W081 E. Neuropsychiatric conditions 3,928 3,061 2,208 3,281 2,620 3,948 4,507 2,879 2,954
W082 1. Unipolar depressive disorders 1,422 1,154 738 1,018 743 1,239 1,240 1,168 960
W083 2. Bipolar disorder 212 197 231 184 231 211 211 218 187
W084 3. Schizophrenia 253 238 234 186 234 253 253 272 192
W085 4. Epilepsy 169 140 142 46 289 174 144 83 60
W086 5. Alcohol use disorders 14 150 21 643 158 788 1,228 98 372
W087 6. Alzheimer and other dementias* 83 138 73 242 79 142 165 179 233
W088 7. Parkinson disease 74 51 17 45 22 8 13 44 54
W089 8. Multiple sclerosis 23 30 17 32 18 20 23 25 26
W090 9. Drug use disorders 797 99 71 148 71 99 250 48 258
W091 10. Post-traumatic stress disorder 56 57 53 54 53 45 45 57 55
W092 11. Obsessive-compulsive disorder 66 119 113 70 113 120 120 119 45
W093 12. Panic disorder 106 103 103 97 104 101 101 107 97
W094 13. Insomnia (primary) 73 59 58 76 58 75 75 33 76
W095 14. Migraine 111 110 51 236 51 151 151 115 136
W098 F. Sense organ diseases 1,545 592 2,116 424 2,113 924 944 909 300
W099 1. Glaucoma 14 33 221 18 221 54 55 44 5
W100 2. Cataracts 737 55 1,227 18 1,225 299 305 80 5
W101 3. Vision disorders, age-related 121 208 228 63 228 278 286 324 46
W102 4. Hearing loss, adult onset 666 293 440 325 439 294 298 462 245
W104 G. Cardiovascular diseases 6,749 2,997 1,713 849 3,495 2,468 1,556 3,019 901
W105 1. Rheumatic heart disease 268 26 56 16 142 4 6 66 10
W106 2. Hypertensive heart disease 680 79 94 23 183 185 64 102 17
W107 3. Ischaemic heart disease 3,169 1,107 520 313 1,040 525 547 1,750 452
W108 4. Cerebrovascular disease 1,123 1,006 615 271 1,230 1,115 511 855 246
W109 5. Inflammatory heart diseases 339 52 94 55 238 18 75 189 49
W111 H. Respiratory diseases 1,299 365 556 888 1,257 685 900 474 1,096
W112 1. Chronic obstructive pulmonary disease 367 133 180 291 370 248 181 240 683
W113 2. Asthma 462 132 106 201 232 276 248 161 329
W115 I. Digestive diseases 2,197 542 599 480 1,481 957 504 676 264
W116 1. Peptic ulcer disease 61 12 42 17 95 10 8 77 14
W117 2. Cirrhosis of the liver 630 - 136 149 343 377 93 186 56
W118 3. Appendicitis 5 4 4 4 10 8 4 6 3
05/18/2010 + ^

17. W120 J. Genitourinary diseases 905 311 289 92 615 362 207 317 111
W121 1. Nephritis and nephrosis 644 179 134 32 407 240 103 92 27
W122 2. Benign prostatic hypertrophy 52 25 72 20 69 57 57 67 20
W124 K. Skin diseases 64 22 179 12 107 112 68 45 8
W125 L. Musculoskeletal diseases 462 708 460 379 506 543 519 541 390
W126 1. Rheumatoid arthritis 74 133 56 80 62 118 121 80 71
W127 2. Osteoarthritis 204 395 290 186 290 215 221 244 209
W131 M. Congenital anomalies 1,050 221 134 250 408 346 449 835 245
W143 N. Oral conditions 133 120 98 89 98 170 171 207 86
W144 1. Dental caries 85 71 50 57 50 141 141 135 57
W145 2. Periodontal disease 9 5 6 4 6 5 5 4 4
W146 3. Edentulism 37 43 41 27 41 23 23 65 25
W148 III.Injuries 4,887 2,688 2,723 1,047 8,026 1,403 1,931 1,383 1,107
W149 A. Unintentional injuries 3,470 2,397 1,578 893 5,397 956 1,208 1,228 804
W150 1. Road traffic accidents 1,237 153 551 417 2,028 376 394 260 264
W151 2. Poisonings 129 37 70 78 288 10 14 35 117
W152 3. Falls 409 309 89 126 279 69 91 140 112
W153 4. Fires 253 60 128 10 372 20 33 77 14
W154 5. Drownings 276 36 101 16 504 62 73 63 35
W155 6. Other unintentional injuries 1,166 1,802 638 246 1,928 420 602 653 263
W156 B. Intentional injuries 1,417 291 1,146 154 2,629 447 723 154 304
W157 1. Self-inflicted injuries 269 66 70 124 271 20 220 57 260
W158 2. Violence 220 168 538 29 1,823 423 497 93 43
W159 3. War 891 52 537 0 535 4 2 4 -
Refer to Notes sheet for notes on this table.
05/18/2010 + ^